The 15th Annual Johns Hopkins Multiple Sclerosis Symposium Series

Released On
November 17, 2021

Expires On
November 17, 2022

Media Type
Internet

Completion Time
90 minutes

Specialty
Neurology

Topic(s)
Multiple Sclerosis

Scroll to the Bottom of this Information to Begin this Course

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Johns Hopkins University School of Medicine and Catalyst Medical Education, LLC. The Johns Hopkins University School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.

This nursing continuing professional development activity is jointly provided with The Institute for Johns Hopkins Nursing. The Institute for Johns Hopkins Nursing is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.



 

This activity is supported by an educational grant from Biogen and Bristol-Meyers Squibb.

Credit Available

  • Physicians — maximum of 1.5 AMA PRA Category 1 Credit(s)
  • Nurses — 1.5 Contact Hours

All other health care professionals completing this course will be issued a statement of participation.

Target Audience

This activity is intended for Primary care clinicians (physicians, NPs, PAs), nurses, neurology clinicians (physicians, NPs, PAs), advanced practice nurses and other healthcare providers who may participate in the assessment and care of individuals with MS.

Program Overview

Although there is no medication that can fully prevent or reverse the neurologic deterioration associated with multiple sclerosis (MS), the use of disease-modifying therapy (DMT) is widely recommended to favorably impact prognosis and reduce disability. The number of DMTs now approved by the US Food and Drug Administration has grown substantially, resulting in more options for patients, but also increasing the complexity of starting, stopping, and switching treatments for healthcare providers (HCPs), who must consider the different modes of administration (injectable, oral, or intravenous), pharmacologic profiles, and benefit-risk profiles, in the context of individual- and disease-specific factors. Thus, although it is encouraging to have many options that have been shown to reduce the frequency and severity of relapses, to limit the development of new lesion activity, and to delay the progression of disability, many clinicians struggle to find the time and skills needed to appraise the large body of available safety and efficacy data for these DMTs and to translate that information into optimal treatment choices for their patients. Furthermore, suboptimal management of the whole patient (ie, focusing on the symptoms or relapses while ignoring other impacts and burdens on the patient), and the lack of shared decision-making may result in the selection of a treatment approach that is out of sync with an individual’s values, preferences, and therapy goals.

Management of MS as a chronic, multifaceted disease requires multidisciplinary care from a collaborative team of specialty and primary care HCPs. This opportunity seeks to facilitate this team-based care by providing education in a format that addresses both the unique and common educational needs of specialty and primary care HCPs, provides a forum in which to share the latest evidence-based information, and explores best practices for MS care in a primary care setting, specialty setting, and collaborative setting.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Facilitate strategies that support the early recognition and treatment of multiple sclerosis
  • Assess clinical trial and real-world efficacy and safety data for DMTs recently approved for relapsing and progressive forms of MS 
  • Propose effective shared decision making and collaborative care strategies to optimize MS management plans 

 

Faculty

FACULTY_NAME

Scott Newsome, DO, MSCS, FAAN, FANA (Chairperson)

Associate Professor of Neurology
Director, Neurosciences Consultation and Infusion Center at Green Spring Station
Director, Stiff Person Syndrome Center
Co-Director, Multiple Sclerosis Experimental Therapeutics Program
Co-Director, Johns Hopkins Neuroimmunology Clinical Fellowship Program
Member, Miller-Coulson Academy of Clinical Excellence
Johns Hopkins Hospital
Division of Neuroimmunology and Neuroinfectious Diseases
Baltimore, Maryland

FACULTY_NAME

Lisa Fox, PA-C

Associate Director
Department of Neurology
Neurology Outpatients Infusion Center
Baltimore, Maryland

FACULTY_NAME

Jiwon Oh, MD, PhD, FRCPC

Staff Neurologist
Medical Director, of the Barl Multiple Sclerosis Program
St. Michael’s HospitalUniversity of Toronto
Toronto, Canada

 

Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Johns Hopkins University School of Medicine and Catalyst Medical Education, LLC. The Johns Hopkins University School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.

The Institute for Johns Hopkins Nursing is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.

Credit Designation

CME/CNE CREDIT

Physicians
The Johns Hopkins University School of Medicine designates this webcast archive for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing
To receive contact hours, listen to the entire activity, pass the posttest with a 70% and complete the evaluation form. At the end of the program, you will be provided with a certificate stating the contact hours for this program.

Policy on Presenter and Provider Disclosure

It is the policy of the Johns Hopkins School of Medicine that the presenter and provider globally disclose conflicts of interest. The Johns Hopkins School of Medicine OCME has established policies that will identify and resolve conflicts of interest prior to this educational activity. Detailed disclosure will be made prior to presentation of the education.

Full Disclosure Policy Affecting CME Activities

As a provider approved by the Accreditation Council for Continuing Medical Education (ACCME), Johns Hopkins School of Medicine Office of Continuing Medical Education (OCME) requires attested and signed global disclosure of the existence of all financial interests or relationships with commercial interest from any individual in a position to control the content of a CME activity sponsored by OCME. The following relationships have been reported for this activity:

Scott Newsome, DO, MSCS, FAAN, FANA

  • Advisor: Autobahn Therapeutics, BioIncept.
  • Advisory Board: Biogen Idec, Bristol Myers Squibb, EMD Serono, Genentech, Inc., Greenwich Biosciences, Novartis AG.
  • Clinical Adjudication Committee Member: MedDay Pharmaceuticals
  • Consultant: Biogen Idec, BioIncept, Bristol Myers Squibb, EMD Serono, Genentech, Inc., Greenwich Biosciences, Novartis AG
  • Principal Investigator: Biogen Idec, Genentech, Inc., Roche
 

Lisa Fox, PA

  • Consultant: Biogen Idec, Genentech, Inc., Genzyme Corporation, Novartis AG
 

Jiwon Oh, MD, PhD, FRCPC

  • Consultant: Biogen Idec, EMD Serono, Genzyme Corporation, Novartis AG, Roche
 

No one else in a position to control the content of this educational activity has disclosed a relevant financial interest or relationship with any commercial interest.

Note: Grants to investigators at the Johns Hopkins University are negotiated and administered by the institution that receives the grants, typically through the Office of Research Administration. Individual investigators who participate in the sponsored project(s) are not directly compensated by the sponsor, but may receive salary or other support from the institution to support their effort on the project(s).

Instructions for Participation and Credit

How to Participate in This Activity and Obtain CME Credit and Nursing Contact Hours: Statements of credit will be awarded based on the participant reviewing activity, scoring a 70% or higher on the post test, and completing and submitting an activity evaluation. A statement of credit will be available upon completion of an online evaluation/claimed credit form. You must participate in the entire activity to receive credit. There is no fee to participate in this activity.

Johns Hopkins Statement of Responsibility

The Johns Hopkins School of Medicine takes responsibility for the content, quality, and scientific integrity of this CME activity.

Copyright

All rights reserved - The Johns Hopkins School of Medicine. No part of this program may be used or reproduced in any manner whatsoever without written permission except in the case of brief quotations embodied in articles or reviews.

Internet CME Policy

The Office of Continuing Medical Education (OCME) at the Johns Hopkins School of Medicine is committed to protecting the privacy of its members and customers. Johns Hopkins School of Medicine OCME maintains its internet site as an information resource and service for physicians, other health professionals and the public. OCME at the Johns Hopkins School of Medicine will keep your personal and credit information confidential when you participate in a CME Internet based program. Your information will never be given to anyone outside of the Johns Hopkins School of Medicine CME program. CME collects only the information necessary to provide you with the services that you request.

Disclaimer Statement

The opinions and recommendations expressed by faculty and other experts whose input is included in this program are their own. This enduring material is produced for educational purposes only. Use of Johns Hopkins School of Medicine name implies review of educational format design and approach. Please review the complete prescribing information of specific drugs or combination of drugs, including indications, contraindications, warnings and adverse effects before administering pharmacologic therapy to patients.

Americans with Disabilities Act

The Johns Hopkins School of Medicine (and the Institute for Johns Hopkins Nursing) fully complies/comply with the legal requirements of the ADA and the rules and regulations thereof. Please notify us if you have any special needs.

Course Format - Method of Participation

There are no fees for participating and receiving CME/CNE credit for this enduring activity.

This enduring material is expected to take approximately 1.5 hours to complete. Once the activity is completed, you must pass the post-test and complete the evaluation with attestation to receive CME/CNE credit.

POST-TEST
A post-test will be conducted at the conclusion of the activity. A grade of at least 70% within three attempts is needed to receive CME/CNE credit.

Certificates will be emailed to the participant.

Course Viewing Requirements

Supported Browsers:
Internet Explorer 8.0+ for Windows 2003, Vista, XP, Windows 7, Windows 8.1 and above
Google Chrome 28.0+ for Windows, Mac OS, or Linux
Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux
Safari 6.0+ for Mac OSX 10.7 and above

Supported Phones & Tablets:
Android 4.0.3 and above
iPhone/iPad with iOS 6.1 or above

Confidentiality Disclaimer for CME/CNE Activity Participant

I certify that I am participating in this Johns Hopkins School of Medicine activity for CME/CNE-accredited training and/or educational purposes.

I understand that while I am participating in this capacity, I may be exposed to "protected health information," as that term is defined and used in Hopkins policies and in the federal HIPAA privacy regulations (the “Privacy Regulations”). Protected health information is information about a person's health or treatment that identifies the person.

I pledge and agree to use and disclose any of this protected health information only for the training and/or educational purposes of my visit and to keep the information confidential. I agree not to post or discuss this protected health information, including pictures and/or videos, on any social media site (eg, Facebook, Twitter, etc.), in any electronic messaging program or through any portable electronic device.

I understand that I may direct to the Johns Hopkins Privacy Officer any questions I have about my obligations under this Confidentiality Pledge or under any of the Hopkins policies and procedures and applicable laws and regulations related to confidentiality. The contact information is: Johns Hopkins Privacy Officer, telephone: 410-614-9900 , e-mail: HIPAA@jhmi.edu.

The Office of Continuing Medical Education at the Johns Hopkins School of Medicine, as sponsor of this activity, has relayed information with the CME attendees/participants and certify that the visitor is here for training, education and/or observation purposes only.”

For CME questions, please contact the CME Office 410-955-2959 or cmenet@jhmi.edu.

For CME Certificates, please call (410) 502-9636.

Johns Hopkins School of Medicine
Office of Continuing Medical Education
720 Rutland Avenue/ Turner 20
Baltimore, Maryland 21205-2195
Reviewed & Approved by: General Counsel, Johns Hopkins Medicine (4/1/03)
(Updated 4/09 and 3/14)

For CNE questions please contact: rbarshi1@jhmi.edu